Minnesota Lynx forward Napheesa Collier has announced a groundbreaking partnership with Opill®. The collaboration aims to improve access to reproductive healthcare through America’s first over-the-counter daily birth control pill.
WNBA Champion Takes Bold Stance on Women’s Health
The two-time Olympic Gold Medalist brings her influential voice to reproductive health advocacy. Collier’s partnership with Opill® builds upon the company’s existing relationship with the Women’s National Basketball Association.
“I just really believe in everything that they’re doing at Opill®,” Collier tells ESSENCE. Her commitment stems from a deep-rooted belief in expanding healthcare accessibility for women.
Revolutionary Over-the-Counter Birth Control Access
Opill® marks a historic milestone as the first FDA-approved daily birth control pill available without prescription. This development removes traditional barriers to contraceptive access across the United States.
“It’s affordable, it’s accessible. You don’t need a prescription to get it,” Collier emphasizes. The partnership aims to educate women about their reproductive health options during challenging times.
College Campus Initiative Tackles Reproductive Health Education
Collier plans to visit college campuses during the WNBA off-season. These visits will focus on discussing reproductive freedoms with students and breaking down stigmas.
Growing up with a nurse mother, Collier experienced open dialogue about reproductive health. “Having the conversation around that is essential to remove the stigma,” she explains.
Motherhood Shapes Advocacy Mission
As a mother to daughter Mila, Collier feels personally invested in the future of women’s healthcare. She emphasizes the importance of creating an environment where discussions about reproductive health become normalized.
“Being able to talk about these things and having women learn about their rights and bodies creates a safer and healthier society,” Collier states. Her advocacy work reflects both personal and professional commitments.
